NASDAQ:PETS - Petmed Express Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$26.28 -1.06 (-3.88 %)
(As of 11/16/2018 03:02 PM ET)
Previous Close$27.34
Today's Range$25.78 - $27.09
52-Week Range$26.16 - $57.80
Volume37,844 shs
Average Volume815,042 shs
Market Capitalization$557.58 million
P/E Ratio14.47
Dividend Yield4.00%
Beta0.84
PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. It also sells food, beds, crates, stairs, strollers, and other pet supplies. The company sells its products through its Internet Website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
Current SymbolNASDAQ:PETS
Previous Symbol
CUSIP71638210
Phone561-526-4444

Debt

Debt-to-Equity RatioN/A
Current Ratio6.99
Quick Ratio5.31

Price-To-Earnings

Trailing P/E Ratio14.47
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$273.80 million
Price / Sales1.98
Cash Flow$1.8638 per share
Price / Cash14.10
Book Value$6.28 per share
Price / Book4.18

Profitability

EPS (Most Recent Fiscal Year)$1.82
Net Income$37.28 million
Net Margins14.88%
Return on Equity35.53%
Return on Assets29.82%

Miscellaneous

Employees187
Outstanding Shares20,670,000
Market Cap$557.58 million
OptionableOptionable

Petmed Express (NASDAQ:PETS) Frequently Asked Questions

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express declared a quarterly dividend on Tuesday, October 23rd. Stockholders of record on Monday, November 5th will be given a dividend of $0.27 per share on Friday, November 16th. This represents a $1.08 annualized dividend and a dividend yield of 4.11%. The ex-dividend date of this dividend is Friday, November 2nd. View Petmed Express' Dividend History.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) released its quarterly earnings results on Monday, October, 22nd. The company reported $0.52 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.50 by $0.02. The business earned $71.40 million during the quarter, compared to analyst estimates of $71.93 million. Petmed Express had a return on equity of 35.53% and a net margin of 14.88%. The firm's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.43 EPS. View Petmed Express' Earnings History.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release their next quarterly earnings announcement on Monday, January 28th 2019. View Earnings Estimates for Petmed Express.

What price target have analysts set for PETS?

3 brokers have issued 1-year target prices for Petmed Express' shares. Their predictions range from $32.00 to $58.00. On average, they anticipate Petmed Express' stock price to reach $45.00 in the next twelve months. This suggests a possible upside of 71.2% from the stock's current price. View Analyst Price Targets for Petmed Express.

What is the consensus analysts' recommendation for Petmed Express?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Petmed Express.

Has Petmed Express been receiving favorable news coverage?

Media stories about PETS stock have been trending somewhat negative recently, according to InfoTrie Sentiment. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Petmed Express earned a daily sentiment score of -1.5 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near term.

Who are some of Petmed Express' key competitors?

Who are Petmed Express' key executives?

Petmed Express' management team includes the folowing people:
  • Mr. Menderes Akdag, CEO, Pres & Director (Age 57)
  • Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 49)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.72%), Renaissance Technologies LLC (8.46%), Epoch Investment Partners Inc. (4.15%), Penserra Capital Management LLC (2.35%), Bank of New York Mellon Corp (1.69%) and Copeland Capital Management LLC (1.63%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.

Which institutional investors are selling Petmed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including Prudential Financial Inc., Credit Suisse AG, Allianz Asset Management GmbH, First Trust Advisors LP, Copeland Capital Management LLC, North Star Investment Management Corp., Hsbc Holdings PLC and Uniplan Investment Counsel Inc.. Company insiders that have sold Petmed Express company stock in the last year include Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Insider Buying and Selling for Petmed Express.

Which institutional investors are buying Petmed Express stock?

PETS stock was purchased by a variety of institutional investors in the last quarter, including Epoch Investment Partners Inc., BlackRock Inc., New Amsterdam Partners LLC NY, Menlo Advisors LLC, Renaissance Technologies LLC, Point72 Asset Management L.P., Penserra Capital Management LLC and Capital Fund Management S.A.. View Insider Buying and Selling for Petmed Express.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $26.28.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $557.58 million and generates $273.80 million in revenue each year. The company earns $37.28 million in net income (profit) each year or $1.82 on an earnings per share basis. Petmed Express employs 187 workers across the globe.

What is Petmed Express' official website?

The official website for Petmed Express is http://www.1800petmeds.com.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.


MarketBeat Community Rating for Petmed Express (NASDAQ PETS)

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  133 (Vote Outperform)
Underperform Votes:  322 (Vote Underperform)
Total Votes:  455
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/16/2018 by MarketBeat.com Staff

Featured Article: What is Cost of Debt?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel